JoukovV, PajusolaK, KaipainenA, et al.A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J, 1996:15(2):290–298.
2.
FavierB, AlamA, BarronP, et al.Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood, 2006; 108(4):1243–1250.
3.
NewmanB, LoseF, KeddaM-A, et al.Possible genetic predisposition to lymphedema after breast cancer. Lymphat Res Biol, 2012; 10(1):2–13.
4.
MiaskowskiC, DoddM, PaulSM, et al.Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery. PLoS One, 2013; 8(4):e60164.
5.
FuMR, ConleyYP, AxelrodD, et al.Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk prediction. Breast, 2016; 29:231–240.
